000661.SZ
长春高新
SZSE · Healthcare · C 制造业 · CN
CNY 76.11
−4.26%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 11.7B | 12.1B | 13.5B | 14.6B | 12.6B |
| Cost of Revenue | 2.4B | 2.2B | 1.9B | 2.0B | 1.5B |
| Gross Profit | 9.3B | 9.9B | 11.5B | 12.5B | 11.1B |
| Operating Expenses | |||||
| R&D Expense | 2.4B | 2.5B | 2.2B | 1.7B | 1.4B |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 1.4B | 1.5B | 1.2B | 956.9M | 823.7M |
| Selling & Marketing Expense | 4.8B | 5.1B | 4.4B | 4.0B | 3.8B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 8.8B | 9.2B | 7.8B | 6.6B | 6.0B |
| Cost and Expenses | 11.1B | 11.3B | 9.7B | 8.7B | 7.5B |
| Operating Income (EBIT) | 182.7M | 393.3M | 3.3B | 5.6B | 5.0B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (201.9M) | 462.9K | 3.1B | 5.5B | 4.9B |
| Income Tax Expense | 20.6M | 24.0M | 431.8M | 734.5M | 708.9M |
| Bottom Line | |||||
| Net Income | (42.0M) | 155.0M | 2.6B | 4.5B | 4.1B |
| Earnings from Cont. Ops | (222.5M) | (23.5M) | 2.7B | 4.8B | 4.2B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (42.0M) | 155.0M | 2.6B | 4.5B | 4.1B |
| Per Share | |||||
| Basic EPS | (CN¥0.09) | CN¥0.39 | CN¥6.42 | CN¥11.21 | CN¥10.29 |
| Diluted EPS | (CN¥0.09) | CN¥0.39 | CN¥6.42 | CN¥11.06 | CN¥10.16 |
| Revenue Per Share | CN¥29.21 | CN¥30.41 | CN¥33.47 | CN¥36.03 | CN¥31.38 |
| Shares | |||||
| Basic Shares Outstanding | 399.6M | 397.4M | 402.3M | 404.3M | 402.4M |
| Diluted Shares Outstanding | 399.6M | 397.4M | 402.3M | 404.3M | 402.4M |
| Profitability Metrics | |||||
| EBITDA | — | 1.2B | 3.9B | 6.1B | 5.4B |
| D&A | — | 765.0M | 610.7M | 523.1M | 401.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026